Research, development and production to support clinical trials for HIV vaccines
Ended Awarded Last action
- Contract number
- HHSN26100028
- Awardee
-
Leidos Biomedical Research Inc. UEI HV8BH9BPG8Y9 Part of Leidos Holdings, Inc.
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $8,782,079
Award facts
- Opportunity
-
- N01CO5240180 Solicitation number
- Operations and Technical Support for the Frederick National Laboratory for Cancer Research (FLNCR), a Federally Funded Research and Development Center (FFRDC) Award Notice · Posted Apr 27, 2015
- Contract value 100% obligated
- $8,782,079.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Institute of Allergy and Infectious Diseases National Institutes of Health, Department of Health and Human Services
- NAICS code
- 561210 Facilities Support Services
- Set-aside
- No set-aside
- Competition
- Not Competed Only One Source
- Pricing
- Cost No Fee
- Place of performance
- Frederick, MD 21702, USA
- Legislative mandates
-
- Economy Act FAR subpart 17.5
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $424,425 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $59,626 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $8,298,028 |
About this award
This is a $8,782,079.00 delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Leidos Biomedical Research Inc. The contract is for research, development, and production to support clinical trials for HIV vaccines. Leidos Biomedical Research Inc. is a subsidiary of Leidos Holdings, Inc. and operates as a Federally Funded Research and Development Center (FFRDC) contractor for the National Cancer Institute (NCI), providing a range of biomedical research and facilities support services. This contract does not have a set-aside designation. Leidos Biomedical Research Inc. has a single-award Indefinite Delivery Contract from the NCI valued at up to $6.6 billion over 5 years, which establishes the company as an FFRDC to deliver a variety of services through task orders.
Quick answers
Who was awarded contract HHSN26100028?
HHSN26100028 was awarded to Leidos Biomedical Research Inc. by National Cancer Institute (National Institutes of Health) on September 16, 2016.
How much is contract HHSN26100028 worth?
The government has obligated $8,782,079 on HHSN26100028.
Which agency awarded contract HHSN26100028?
National Cancer Institute (National Institutes of Health) awarded HHSN26100028, with funding from National Institute of Allergy and Infectious Diseases (National Institutes of Health).
Is contract HHSN26100028 an order under another contract?
Yes. HHSN26100028 is a delivery order under HHSN261201500003I, an indefinite delivery contract.
Was contract HHSN26100028 competed?
The extent of competition for HHSN26100028 was not competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award